Welcome to our dedicated page for ASTERA LABS SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Astera Labs, Inc. SEC filings page for ticker ALAB provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Nasdaq-listed semiconductor company focused on rack-scale AI infrastructure, Astera Labs uses these filings to report material events, financial results, and other information relevant to investors.
Recent filings include multiple Form 8-K reports. Some of these 8-Ks furnish press releases covering quarterly financial results, described under Item 2.02, “Results of Operations and Financial Condition.” Others report material events such as Astera Labs entering into a definitive agreement to acquire aiXscale Photonics GmbH, disclosed under Item 8.01, “Other Events.” These documents link directly to the company’s public communications and provide the formal regulatory record.
Through this page, users can locate Astera Labs’ quarterly earnings information as furnished in Form 8-K, along with other current reports that explain significant developments in the business. While the examples provided reference 8-K filings, the broader filings history may also include annual reports on Form 10-K, quarterly reports on Form 10-Q, and other forms that detail the company’s financial condition, risk factors, and governance matters.
Stock Titan enhances these filings with AI-powered summaries that help explain key points from lengthy documents, such as earnings releases or transaction announcements. Real-time updates from EDGAR allow investors to see new ALAB filings as they appear, while AI-generated highlights can make it easier to understand how specific disclosures relate to Astera Labs’ rack-scale AI connectivity strategy, collaborations with hyperscalers, and acquisitions such as the aiXscale Photonics agreement.
ALAB submitted a Form 144 notice for proposed sales of Common stock on 04/17/2026 relating to shares held or acquired in prior private placements and distributions. The filing lists broker/dealer Stifel (501 N Broadway, St. Louis) and multiple grant/purchase dates with share counts tied to those issuances.
Astera Labs, Inc. reported multiple proposed and completed sales of Common Stock by related parties under Rule 144 and transfers of issued shares. The filing lists transfers to Jitendra Mohan (71,730 RSUs on 12/01/2025; 340,770 Founder Shares on 11/21/2017) and four reported sales during Feb–Apr 2026 totaling 433,188 shares with disclosed gross proceeds: $11,758,145.75, $20,723,774, $18,522,450, and $518,036.
The notices identify Jitendra Mohan and the Mohan & Samant 2022 Living Trust as sellers and show transactions dated 02/17/2026, 03/17/2026, 04/10/2026, and 04/15/2026. The filing is a disclosure of affiliate sales activity rather than company-operated offers.
Astera Labs, Inc. Chief Executive Officer Mohan Jitendra, through a living trust, reported open-market sales of Common Stock. On April 15, 2026, the living trust sold 2,767 shares at $174.5682 per share and 200 shares at $175.03 per share.
The filing states these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025, indicating they were scheduled in advance. Following the trades, the living trust holds 4,405,015 shares, and the filing also lists additional indirect holdings in multiple estate-planning trusts and a direct holding of 1,452,739 shares of Common Stock.
Astera Labs submitted a Form 144 notice reporting proposed transfers of common stock by Jitendra Mohan and related trust. The excerpt lists four planned transfers dated 12/01/2025 totaling 204,750 shares from RSU issuances, and three sales filed as completed in the past three months: 94,971, 157,500, and 123,750 shares with corresponding gross proceeds shown.
Astera Labs, Inc. reported that a living trust associated with Chief Executive Officer Mohan Jitendra sold 123,750 shares of Common Stock in open-market transactions. The trust sold 99,023 shares at a weighted average price of $149.5322 per share and 24,727 shares at a weighted average price of $150.2535 per share.
The filing states these sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025. After the sales, the living trust reported holding 4,407,982 shares indirectly, and the filing also lists additional indirect holdings in several estate planning trusts and 1,452,739 shares held directly.
Astera Labs, Inc. director Manuel Alba reported that entities associated with him executed open-market sales of 183,000 shares of Astera Labs common stock on April 1, 2026. The trades were carried out automatically under a Rule 10b5-1 trading plan adopted on May 29, 2025, at weighted-average prices between approximately $105.85 and $111.27 per share.
After these sales, the Alba 2003 Living Trust held 1,424,498 shares, Casa Alameda 2007, LLC held 319,863 shares, Alba’s spouse held 5,000 shares, and he held 2,351 shares directly. The filing notes that Alba disclaims beneficial ownership of the trust and LLC shares beyond any pecuniary interest.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara sold a total of 10,000 shares of common stock in open-market transactions on April 1, 2026, at weighted average prices ranging from just over $105 to about $111 per share.
The filing notes these sales occurred automatically under a pre-arranged Rule 10b5-1 trading plan adopted on May 29, 2025. Following the transactions, Mazzara continues to hold 118,584 shares of Astera Labs common stock directly.
ALAB related sale notice filed via Form 144. The filing lists 150,000 shares of Common stock proposed for sale, dated 04/01/2026. The securities were acquired privately on 03/21/2018 as a Private Acquisition from Issuer or an Affiliate and the filing shows a dollar amount of $16,440,000.00.
ALAB affiliate intends to sell 33,000 shares. A Form 144 filing lists 33,000 Common shares associated with Morgan Stanley Smith Barney LLC, a proposed aggregate amount of $3,616,800.00, and indicates the securities were privately acquired from the issuer or an affiliate on 11/30/2018. The filing date is 04/01/2026 and the shares are listed for sale on NASDAQ.
ALAB proposed the sale of 170,000 shares of Common Stock under Form 144. The filing lists Morgan Stanley Smith Barney LLC, Executive Financial Services, as the filer and shows the shares were acquired on 03/21/2018 by private acquisition from issuer or an affiliate. The filing records $18,632,000.00 on the securities line and includes an anchor date of 04/01/2026.